This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Eutilex Co., Ltd., National Cancer Center. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: **Innovations in Cancer Treatment: The Contributions of Byung-Kiu Park**
Introduction
Byung-Kiu Park is a notable inventor based in Seoul, South Korea, recognized for his groundbreaking contributions to cancer treatment through innovative methods involving CD8T cells. With a total of two patents to his name, Park's work stands at the forefront of medical research, particularly in the realm of personalized immunotherapy.
Latest Patents
Park's latest patents focus on methods that allow for the isolation and proliferation of autologous cancer antigen-specific CD8T cells. These methods involve selecting epitopes recognized by CD8T cells from the patient's own cancer antigens, which are present in their blood. By employing peptides of the chosen epitopes, Park's method enables the isolation of these specific T cells, which can then be massively proliferated. The significance of this innovation lies in its potential to effectively identify and eliminate cancer cells derived from the patient's own body, providing a targeted approach to treatment that minimizes side effects.
Career Highlights
Throughout his career, Byung-Kiu Park has made significant strides in oncology research. Notable institutions where he has applied his expertise include the National Cancer Center and Eutilex Co., Ltd. These affiliations have allowed him to collaborate with esteemed professionals in his field and contribute to advancements in cancer therapies.
Collaborations
In his research endeavors, Park has worked alongside fellow researchers, including Byoung S. Kwon and Hyun-Guy Kang. These collaborations have facilitated the sharing of ideas and expertise, further enriching the innovative landscape of cancer treatment methodologies.
Conclusion
Byung-Kiu Park's contributions to the field of cancer treatment through innovative techniques for isolating and proliferating autologous CD8T cells showcase the profound impact that dedicated inventors can have on medicine. His work not only advances scientific knowledge but also holds the promise of improving the lives of cancer patients by offering more effective and personalized treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile